CD8A and myeloid sarcoma: These data were supported by studies performed in ALS patients showing an increased activation of peripheral and intrathecal CD8+ T cells, with the activation status of CD8+ lymphocytes in the blood being higher in ALS compared to MS and dementia, further suggesting a role for cytotoxic lymphocytes in ALS (160).